Trials / Completed
CompletedNCT00643656
Use of 50% Nitrous Oxide / 50% Oxygen Premix During Liver Biopsy of Focal Lesion
Study of the Efficiency of Kalinox 170 Bar During Liver Biospy of Focal Lesion
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 94 (estimated)
- Sponsor
- Air Liquide Santé International · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A 50% nitrous oxide / 50% oxygen premix is administrated to the patient during the realization of liver biopsy in order to relax him and to reduce his pain during this painful medical treatment. This single investigator centre and national clinical trial is done blindly : half of patients will receive 50% nitrous oxide / 50% oxygen premix and half of them a placebo gas (mixture of 50% oxygen and 50% nitrogen). 94 patients will be included in this clinical protocol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Kalinox 170 bar | Flow of gas administrated to the patient between 4 and 15 litre/min and less than 1 hour |
| DRUG | Mix of 50% oxygen and 50% nitrogen | Flow of gas administrated to the patient between 4 and 15 litre/min and less than 1 hour |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2008-06-01
- Completion
- 2008-12-01
- First posted
- 2008-03-26
- Last updated
- 2025-03-13
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00643656. Inclusion in this directory is not an endorsement.